BRIP1 p.Arg419Trp
c.1255C>T · rs150624408 · VCV128153
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1902 | likely benign |
|---|---|---|
| REVEL | 0.605 | indeterminate |
| SaProt | LLR -11.13 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.7 | GERP -0.32, phastCons 1 |
| Regional constraint | o/e 0.92 | unconstrained · MANE · 68 kb · p 0.065 · regional, not allelic |
| Overall | ||
| CADD | 25.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0604% | 1,656 |
| European (non-Finnish) | 0.0283% | 3,532 |
| Remaining individualsnot grpmax-eligible | 0.024% | 4,165 |
| Ashkenazi Jewishnot grpmax-eligible | 0.0237% | 4,227 |
| Finnishnot grpmax-eligible | 0.0141% | 7,114 |
| Admixed American | 0.01% | 9,983 |
| African / African-American | 0.00668% | 14,966 |
| East Asian | 0.00223% | 44,878 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRIP1
- Protein
- p.Arg419Trp
- Coding
- c.1255C>T
- MANE Select
- NM_032043
- dbSNP
- rs150624408
- Type
- single nucleotide variant
- Location
- chr17:61799185 (GRCh38)
- Gene constraint
- LOEUF 0.848 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 64.19 · 6 PDB
- Residue 419
- the helicase atp-binding domain; a UniProt-annotated variant site (in)
Disease context
hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary breast ovarian cancer syndromebreast carcinomabreast cancerovarian cancerFanconi anemia complementation group Jhereditary breast carcinoma
Similar variants
- BRIP1 p.Arg419Gln Uncertain significance ★★ ⚠ same residue
- BRIP1 p.Arg419Gly Uncertain significance ★★ ⚠ same residue
- BRIP1 p.Arg419Pro Uncertain significance ★★ ⚠ same residue
- BRIP1 p.Arg419= Conflicting classifications of pathogenicity ★ same residue
- BRIP1 p.Arg419Leu Uncertain significance ★ ⚠ same residue
- BRIP1 p.Arg419fs Pathogenic ★ same residue
- BRIP1 c.1140+1G>A Likely pathogenic ★★ same condition
- BRIP1 c.1141-2A>C Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brip1-p-arg419trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown